Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
May 16, 2022 5:04 PM EDT
The Securities and Exchange Commission has not necessarily reviewed
the information in this filing and has not determined if it is
accurate and complete.
The reader should not assume that the information is accurate
and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
|
| OMB APPROVAL |
| OMB Number: |
3235-0006 |
| Expires: |
July 31, 2015 |
| Estimated average burden |
| hours per response: |
23.8 |
|
|
| Report for the Calendar Year or Quarter Ended: |
03-31-2022 |
| Check here if Amendment |
|
Amendment Number: |
|
| This Amendment (Check only one.): |
|
is a restatement. |
|
|
adds new holdings entries. |
| Institutional Investment Manager Filing
this Report: |
| Name: |
RA CAPITAL MANAGEMENT, L.P. |
| Address: |
200 BERKELEY STREET, 18TH FLOOR |
|
|
|
Boston
,
MA02116
|
| Form 13F File Number: |
028-12884 |
The institutional investment manager filing this report and
the person by whom it is signed hereby represent that the person
signing the report is authorized to submit it, that all information
contained herein is true, correct and complete, and that it is
understood that all required items, statements, schedules, lists, and
tables, are considered integral parts of this form.
| Person Signing this Report on Behalf of
Reporting Manager: |
| Name: |
Rajeev Shah |
| Title: |
Authorized Signatory |
| Phone: |
617-778-2500 |
| Signature, Place, and Date of Signing: |
| /s/ Rajeev Shah |
Boston
,
MA
|
05-16-2022 |
| [Signature] |
[City, State] |
[Date] |
|
| Report Type (Check only one.): |
| X |
13F HOLDINGS REPORT. (Check here if all holdings of
this reporting manager are reported in this report.) |
|
|
13F NOTICE. (Check here if no holdings reported are in
this report, and all holdings are reported by other reporting
manager(s).) |
|
|
13F COMBINATION REPORT. (Check here if a portion of
the holdings for this reporting manager are reported in this
report and a portion are reported by other reporting manager(s).) |
| Form 13F Summary Page |
|
Report Summary: |
|
Number of Other Included
Managers: |
0 |
|
|
|
Form 13F Information Table Entry Total: |
96 |
|
Form 13F Information Table Value Total: |
4,583,149 |
|
(thousands) |
|
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
|
|
|
Form 13F File Number |
Name |
| List of Other Included
Managers: |
|
Provide a numbered list of the name(s) and Form 13F file number(s)
of all institutional investment managers with respect to which this
report is filed, other than the
manager filing this report.
|
|
[If there are no entries in this list, state “NONE” and omit the
column headings and list entries.]
|
|
No. |
Form 13F File Number |
Name |
The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
The reader should not assume that the information is
accurate and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F INFORMATION TABLE
|
| OMB APPROVAL |
| OMB Number: |
3235-0006 |
| Expires: |
July 31, 2015 |
| Estimated average
burden |
| hours per response:
|
23.8 |
|
|
| COLUMN 1 |
COLUMN 2 |
COLUMN 3 |
COLUMN 4 |
COLUMN 5 |
COLUMN 6 |
COLUMN 7 |
COLUMN 8 |
|
|
|
VALUE |
SHRS OR |
SH/ |
PUT/ |
INVESTMENT |
OTHER |
VOTING AUTHORITY |
| NAME OF ISSUER |
TITLE OF CLASS |
CUSIP |
(x$1000) |
PRN AMT |
PRN |
CALL |
DISCRETION |
MANAGER |
SOLE |
SHARED |
NONE |
| 5 01 ACQUISITION CORP |
COM CL A |
33836P105 |
7,388 |
750,000 |
SH |
|
SOLE |
|
750,000 |
0 |
0 |
| 89BIO INC |
COM |
282559103 |
18,721 |
4,965,769 |
SH |
|
SOLE |
|
4,965,769 |
0 |
0 |
| ACHILLES THERAPEUTICS PLC |
SPONSORED ADS |
00449L102 |
14,743 |
5,014,687 |
SH |
|
SOLE |
|
5,014,687 |
0 |
0 |
| ACLARIS THERAPEUTICS INC |
COM |
00461U105 |
31,339 |
1,817,808 |
SH |
|
SOLE |
|
1,817,808 |
0 |
0 |
| ACUMEN PHARMACEUTICALS INC |
COM |
00509G209 |
38,204 |
9,770,773 |
SH |
|
SOLE |
|
9,770,773 |
0 |
0 |
| AEROVATE THERAPEUTICS INC |
COM |
008064107 |
151,479 |
8,263,982 |
SH |
|
SOLE |
|
8,263,982 |
0 |
0 |
| AKOUOS INC |
COM |
00973J101 |
10,836 |
2,281,249 |
SH |
|
SOLE |
|
2,281,249 |
0 |
0 |
| ALLOVIR INC |
COM |
019818103 |
9,724 |
1,440,525 |
SH |
|
SOLE |
|
1,440,525 |
0 |
0 |
| AN2 THERAPEUTICS INC |
COM |
037326105 |
55,257 |
3,666,663 |
SH |
|
SOLE |
|
3,666,663 |
0 |
0 |
| ARYA SCIENCES ACQUISITN |
CLASS A ORD SHS |
G31658100 |
9,710 |
1,000,000 |
SH |
|
SOLE |
|
1,000,000 |
0 |
0 |
| ASCENDIS PHARMA A/S |
SPONSORED ADR |
04351P101 |
888,169 |
7,567,900 |
SH |
|
SOLE |
|
7,567,900 |
0 |
0 |
| ASTRIA THERAPEUTICS INC |
COM |
04635X102 |
8,469 |
1,262,193 |
SH |
|
SOLE |
|
1,262,193 |
0 |
0 |
| AVIDITY BIOSCIENCES INC |
COM |
05370A108 |
40,032 |
2,167,391 |
SH |
|
SOLE |
|
2,167,391 |
0 |
0 |
| BCLS ACQUISITION CORP |
COM CL A |
G0904B105 |
12,338 |
1,250,000 |
SH |
|
SOLE |
|
1,250,000 |
0 |
0 |
| BELLUS HEALTH INC NEW |
COM NEW |
07987C204 |
70,384 |
10,230,274 |
SH |
|
SOLE |
|
10,230,274 |
0 |
0 |
| BIOGEN INC |
COM |
09062X103 |
153,111 |
727,024 |
SH |
|
SOLE |
|
727,024 |
0 |
0 |
| BIOMEA FUSION INC |
COM |
09077A106 |
2,230 |
500,000 |
SH |
|
SOLE |
|
500,000 |
0 |
0 |
| BLACK DIAMOND THERAPEUTICS I |
COM |
09203E105 |
7,174 |
2,589,904 |
SH |
|
SOLE |
|
2,589,904 |
0 |
0 |
| CELLDEX THERAPEUTICS INC NEW |
COM NEW |
15117B202 |
70,675 |
2,075,000 |
SH |
|
SOLE |
|
2,075,000 |
0 |
0 |
| CENTESSA PHARMACEUTICALS PLC |
SPONSORED ADS |
152309100 |
32,087 |
3,577,094 |
SH |
|
SOLE |
|
3,577,094 |
0 |
0 |
| CENTURY THERAPEUTICS INC |
COM |
15673T100 |
11,508 |
914,094 |
SH |
|
SOLE |
|
914,094 |
0 |
0 |
| CHEMOCENTRYX INC |
COM |
16383L106 |
28,980 |
1,155,964 |
SH |
|
SOLE |
|
1,155,964 |
0 |
0 |
| CHINOOK THERAPEUTICS INC |
COM |
16961L106 |
16,360 |
1,000,000 |
SH |
|
SOLE |
|
1,000,000 |
0 |
0 |
| COMPASS THERAPEUTICS INC |
COM |
20454B104 |
730 |
532,958 |
SH |
|
SOLE |
|
532,958 |
0 |
0 |
| CONCERT PHARMACEUTICALS INC |
COM |
206022105 |
10,223 |
3,033,603 |
SH |
|
SOLE |
|
3,033,603 |
0 |
0 |
| CONNECT BIOPHARMA HLDGS LTD |
ADS |
207523101 |
21,113 |
6,991,003 |
SH |
|
SOLE |
|
6,991,003 |
0 |
0 |
| CUE HEALTH INC |
COM |
229790100 |
4,838 |
750,000 |
SH |
|
SOLE |
|
750,000 |
0 |
0 |
| CULLINAN ONCOLOGY INC |
COM |
230031106 |
3,665 |
350,000 |
SH |
|
SOLE |
|
350,000 |
0 |
0 |
| CVRX INC |
COM |
126638105 |
1,647 |
275,000 |
SH |
|
SOLE |
|
275,000 |
0 |
0 |
| CYTEIR THERAPEUTICS INC |
COM |
23284P103 |
12,631 |
3,350,506 |
SH |
|
SOLE |
|
3,350,506 |
0 |
0 |
| CYTEK BIOSCIENCES INC |
COM |
23285D109 |
144,248 |
13,381,054 |
SH |
|
SOLE |
|
13,381,054 |
0 |
0 |
| DA32 LIFE SCNCE TEC ACQSTN C |
CLASS A COM |
23312M106 |
14,573 |
1,500,000 |
SH |
|
SOLE |
|
1,500,000 |
0 |
0 |
| DAY ONE BIOPHARMACEUTICALS I |
COM |
23954D109 |
60,116 |
6,060,090 |
SH |
|
SOLE |
|
6,060,090 |
0 |
0 |
| DESIGN THERAPEUTICS INC |
COM |
25056L103 |
35,314 |
2,186,636 |
SH |
|
SOLE |
|
2,186,636 |
0 |
0 |
| DICE THERAPEUTICS INC |
COM |
23345J104 |
99,646 |
5,208,911 |
SH |
|
SOLE |
|
5,208,911 |
0 |
0 |
| DYNE THERAPEUTICS INC |
COM |
26818M108 |
27,041 |
2,805,045 |
SH |
|
SOLE |
|
2,805,045 |
0 |
0 |
| EDGEWISE THERAPEUTICS INC |
COM |
28036F105 |
25,352 |
2,613,623 |
SH |
|
SOLE |
|
2,613,623 |
0 |
0 |
| ELIEM THERAPEUTICS INC |
COM |
28658R106 |
110,336 |
13,150,849 |
SH |
|
SOLE |
|
13,150,849 |
0 |
0 |
| ENANTA PHARMACEUTICALS INC |
COM |
29251M106 |
68,633 |
964,212 |
SH |
|
SOLE |
|
964,212 |
0 |
0 |
| ENTERA BIO LTD |
SHS |
M40527109 |
6,753 |
2,353,000 |
SH |
|
SOLE |
|
2,353,000 |
0 |
0 |
| EYEPOINT PHARMACEUTICALS INC |
COM NEW |
30233G209 |
40,952 |
3,370,506 |
SH |
|
SOLE |
|
3,370,506 |
0 |
0 |
| FORMA THERAPEUTICS HLDGS INC |
SHS |
34633R104 |
83,808 |
9,011,651 |
SH |
|
SOLE |
|
9,011,651 |
0 |
0 |
| FRAZIER LIFESCIENCES ACQU CO |
CL A SHS |
G3710A121 |
9,990 |
1,000,000 |
SH |
|
SOLE |
|
1,000,000 |
0 |
0 |
| GERON CORP |
COM |
374163103 |
40,972 |
30,126,299 |
SH |
|
SOLE |
|
30,126,299 |
0 |
0 |
| GH RESEARCH PLC |
ORDINARY SHARES |
G3855L106 |
88,292 |
4,827,330 |
SH |
|
SOLE |
|
4,827,330 |
0 |
0 |
| GRAPHITE BIO INC |
COM |
38870X104 |
13,762 |
2,698,369 |
SH |
|
SOLE |
|
2,698,369 |
0 |
0 |
| GUARDANT HEALTH INC |
COM |
40131M109 |
31,555 |
476,380 |
SH |
|
SOLE |
|
476,380 |
0 |
0 |
| HEALTH SCIENCES ACQ CORP 2 |
ORD SHS |
G4411D109 |
6,194 |
625,000 |
SH |
|
SOLE |
|
625,000 |
0 |
0 |
| ICOSAVAX INC |
COM |
45114M109 |
41,983 |
5,963,565 |
SH |
|
SOLE |
|
5,963,565 |
0 |
0 |
| IMMUNOGEN INC |
COM |
45253H101 |
103,489 |
21,741,458 |
SH |
|
SOLE |
|
21,741,458 |
0 |
0 |
| INSTIL BIO INC |
COM |
45783C101 |
52,361 |
4,870,793 |
SH |
|
SOLE |
|
4,870,793 |
0 |
0 |
| IO BIOTECH INC |
COM |
449778109 |
9,846 |
1,857,755 |
SH |
|
SOLE |
|
1,857,755 |
0 |
0 |
| ITEOS THERAPEUTICS INC |
COM |
46565G104 |
142,147 |
4,417,259 |
SH |
|
SOLE |
|
4,417,259 |
0 |
0 |
| JANUX THERAPEUTICS INC |
COM |
47103J105 |
124,337 |
8,670,644 |
SH |
|
SOLE |
|
8,670,644 |
0 |
0 |
| KALA PHARMACEUTICALS INC |
COM |
483119103 |
15,007 |
10,874,613 |
SH |
|
SOLE |
|
10,874,613 |
0 |
0 |
| KALVISTA PHARMACEUTICALS INC |
COM |
483497103 |
28,453 |
1,930,322 |
SH |
|
SOLE |
|
1,930,322 |
0 |
0 |
| KINNATE BIOPHARMA INC |
COM |
49705R105 |
48,014 |
4,264,144 |
SH |
|
SOLE |
|
4,264,144 |
0 |
0 |
| LARIMAR THERAPEUTICS INC |
COM |
517125100 |
5,192 |
1,281,860 |
SH |
|
SOLE |
|
1,281,860 |
0 |
0 |
| LIANBIO |
SPONSORED ADS |
53000N108 |
28,400 |
7,655,015 |
SH |
|
SOLE |
|
7,655,015 |
0 |
0 |
| MACROGENICS INC |
COM |
556099109 |
53,773 |
6,103,594 |
SH |
|
SOLE |
|
6,103,594 |
0 |
0 |
| MILESTONE PHARMACEUTICALS IN |
COM |
59935V107 |
14,423 |
2,246,503 |
SH |
|
SOLE |
|
2,246,503 |
0 |
0 |
| MIRATI THERAPEUTICS INC |
COM |
60468T105 |
60,378 |
734,343 |
SH |
|
SOLE |
|
734,343 |
0 |
0 |
| MORPHIC HLDG INC |
COM |
61775R105 |
11,197 |
278,874 |
SH |
|
SOLE |
|
278,874 |
0 |
0 |
| NATERA INC |
COM |
632307104 |
53,303 |
1,310,289 |
SH |
|
SOLE |
|
1,310,289 |
0 |
0 |
| NKARTA INC |
COM |
65487U108 |
63,786 |
5,605,129 |
SH |
|
SOLE |
|
5,605,129 |
0 |
0 |
| NOVAVAX INC |
COM NEW |
670002401 |
51,024 |
692,794 |
SH |
|
SOLE |
|
692,794 |
0 |
0 |
| OLEMA PHARMACEUTICALS INC |
COM |
68062P106 |
2,149 |
504,505 |
SH |
|
SOLE |
|
504,505 |
0 |
0 |
| ORCHARD THERAPEUTICS PLC |
ADS |
68570P101 |
6,903 |
9,694,789 |
SH |
|
SOLE |
|
9,694,789 |
0 |
0 |
| OTONOMY INC |
COM |
68906L105 |
13,440 |
5,600,000 |
SH |
|
SOLE |
|
5,600,000 |
0 |
0 |
| PARDES BIOSCIENCES INC |
COM |
69945Q105 |
44,584 |
6,175,038 |
SH |
|
SOLE |
|
6,175,038 |
0 |
0 |
| PHASEBIO PHARMACEUTICALS INC |
COM |
717224109 |
3,762 |
2,850,000 |
SH |
|
SOLE |
|
2,850,000 |
0 |
0 |
| PMV PHARMACEUTICALS INC |
COM |
69353Y103 |
35,608 |
1,710,265 |
SH |
|
SOLE |
|
1,710,265 |
0 |
0 |
| POINT BIOPHARMA GLOBAL INC |
COM |
730541109 |
71,754 |
9,003,018 |
SH |
|
SOLE |
|
9,003,018 |
0 |
0 |
| PYXIS ONCOLOGY INC |
COM |
747324101 |
9,220 |
2,282,173 |
SH |
|
SOLE |
|
2,282,173 |
0 |
0 |
| RELAY THERAPEUTICS INC |
COM |
75943R102 |
16,433 |
549,055 |
SH |
|
SOLE |
|
549,055 |
0 |
0 |
| RELMADA THERAPEUTICS INC |
COM |
75955J402 |
53,980 |
2,000,000 |
SH |
|
SOLE |
|
2,000,000 |
0 |
0 |
| RHYTHM PHARMACEUTICALS INC |
COM |
76243J105 |
56,115 |
4,871,067 |
SH |
|
SOLE |
|
4,871,067 |
0 |
0 |
| ROCKET PHARMACEUTICALS INC |
COM |
77313F106 |
33,419 |
2,107,149 |
SH |
|
SOLE |
|
2,107,149 |
0 |
0 |
| RXSIGHT INC |
COM |
78349D107 |
37,794 |
3,052,796 |
SH |
|
SOLE |
|
3,052,796 |
0 |
0 |
| SATSUMA PHARMACEUTICALS INC |
COM |
80405P107 |
22,474 |
5,914,252 |
SH |
|
SOLE |
|
5,914,252 |
0 |
0 |
| SCPHARMACEUTICALS INC |
COM |
810648105 |
15,101 |
2,658,583 |
SH |
|
SOLE |
|
2,658,583 |
0 |
0 |
| SOLID BIOSCIENCES INC |
COM |
83422E105 |
14,841 |
12,367,873 |
SH |
|
SOLE |
|
12,367,873 |
0 |
0 |
| SYNLOGIC INC |
COM |
87166L100 |
16,000 |
6,666,666 |
SH |
|
SOLE |
|
6,666,666 |
0 |
0 |
| TANGO THERAPEUTICS INC |
COM |
87583X109 |
17,055 |
2,250,000 |
SH |
|
SOLE |
|
2,250,000 |
0 |
0 |
| TENAYA THERAPEUTICS INC |
COM |
87990A106 |
41,837 |
3,551,508 |
SH |
|
SOLE |
|
3,551,508 |
0 |
0 |
| TRAVERE THERAPEUTICS INC |
COM |
89422G107 |
126,864 |
4,922,941 |
SH |
|
SOLE |
|
4,922,941 |
0 |
0 |
| TSCAN THERAPEUTICS INC |
COM |
89854M101 |
2,861 |
1,021,764 |
SH |
|
SOLE |
|
1,021,764 |
0 |
0 |
| TYRA BIOSCIENCES INC |
COM |
90240B106 |
77,430 |
7,236,454 |
SH |
|
SOLE |
|
7,236,454 |
0 |
0 |
| VAXCYTE INC |
COM |
92243G108 |
110,636 |
4,581,203 |
SH |
|
SOLE |
|
4,581,203 |
0 |
0 |
| VERA THERAPEUTICS INC |
CL A |
92337R101 |
46,183 |
1,966,084 |
SH |
|
SOLE |
|
1,966,084 |
0 |
0 |
| VERONA PHARMA PLC |
SPONSORED ADS |
925050106 |
25,449 |
5,100,000 |
SH |
|
SOLE |
|
5,100,000 |
0 |
0 |
| VERVE THERAPEUTICS INC |
COM |
92539P101 |
7,081 |
310,284 |
SH |
|
SOLE |
|
310,284 |
0 |
0 |
| VOR BIOPHARMA INC |
COM |
929033108 |
67,171 |
11,120,973 |
SH |
|
SOLE |
|
11,120,973 |
0 |
0 |
| WAVE LIFE SCIENCES LTD |
SHS |
Y95308105 |
15,550 |
7,775,207 |
SH |
|
SOLE |
|
7,775,207 |
0 |
0 |
| WEREWOLF THERAPEUTICS INC |
COM |
95075A107 |
18,884 |
4,291,881 |
SH |
|
SOLE |
|
4,291,881 |
0 |
0 |
| XILIO THERAPEUTICS INC |
COM |
98422T100 |
14,156 |
2,002,217 |
SH |
|
SOLE |
|
2,002,217 |
0 |
0 |
Tweet
Share
E-mail
